Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06527482 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Autologous Osteoperiosteal Transplantation for the Treatment of Severe Osteochondral Lesions of the Talus

StatusUnknown
PhaseNot specified
Started2023-09-01
View on ClinicalTrials.gov ↗
Record status
This record was last updated August 6, 2024 (before its estimated January 1, 2026 completion). Its status may not reflect the trial's current state.

Amendment history

2026-09-06
Trial status changed: Recruiting → Unknown
2024-08-04
Study Status, Outcome Measures v1
Trial statusRecruiting→Unknown
Secondary endpointsdetails revised at 5 of 6 entries
2024-07-25
Original filing
The goal of this clinical trial is to establish a multicenter prospective cohort of patients with severe osteochondral lesion of the talus (OLT), evaluate the clinical efficacy of autologous osteoperiosteal transplantation and the incidence of postoperative donor-site morbidity. The main questions it aims to answer are: Does autologous osteoperiosteal transplantation have good clinical outcomes in the treatment of severe OLT? Does autologous osteoperiosteal transplantation treat severe OLT with fewer postoperative complications? Participants will: Undergo autologous osteoperiosteal transplantation for OLT Receive clinical follow-up 3, 6, 12, and 24 months after surgery and answer scales of ankle function assessment Take CT and MRI preoperatively and 12 and 24 months after surgery
Trial Details
NCT Number NCT06527482
Lead Sponsor Peking University Third Hospital
Conditions Osteochondral Lesion of Talus, Autologous Osteoperiosteal Transplantation
Enrollment 60 participants
Start Date 2023-09-01
Primary Completion 2026-01-01 (estimated)
Study Completion 2026-09-01 (estimated)
Updated on ClinicalTrials.gov 2024-08-06